Sandu Pharmaceuticals Ltd.
Snapshot View

View in App

Prices View details >>

66.50 +0.50 ▲0.8%

12 August 2022, 04:01:00 PM
Volume: 2,035

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.sandu.in
Market Cap 58.59 Cr.
Enterprise Value(EV) 54.42 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 1.80 Trailing Twelve Months Ending 2022-03
Price-Earning Ratio (PE) 36.85 Trailing Twelve Months Ending 2022-03
Industry PE 32.02 Trailing Twelve Months Ending 2022-03
Book Value / Share 31.05 Trailing Twelve Months Ending 2022-03
Price to Book Value 2.14 Calculated using Price: 66.50
Dividend Yield 0.75 Period Ending 2021-03
No. of Shares Subscribed 0.88 Cr. 8,810,664 Shares
FaceValue 10
Company Profile
Sandu Pharmaceuticals incorporated in 1985, is engaged in manufacturing of ayurvedic medicines. The company operates a distribution network in India as well as in the overseas markets.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+0.76%
1 Week
+0.53%
1 Month
3 Month
-5.81%
6 Month
+8.13%
1 Year
+30.52%
2 Year
+166.00%
5 Year
+150.0%
10 Year
+358.62%

Ratios View Details >>

9 years 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03
Return on Equity (%) 4.50 2.76 2.28 2.92 -2.44 3.09 3.53 3.66 5.03
Return on Capital Employed (%) 7.66 6.93 6.80 7.65 5.30 7.06 7.58 5.79 7.87
Return on Assets (%) 2.65 1.41 1.06 1.30 -1.01 1.23 1.52 1.69 2.47

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03* Rs. Cr.
Shh. Funds 18 18 18 19 27 28 29 29 33 36
Non Curr. Liab. 2 3 2 2 1 1 1 1 1 1
Curr. Liab. 14 16 21 21 18 15 14 11 13 12
Minority Int.
Equity & Liab. 33 37 42 41 46 45 44 41 47 49
Non Curr. Assets 9 10 9 9 18 24 24 19 16 26
Curr. Assets 24 27 32 33 28 21 20 22 31 24
Misc. Exp. not W/O
Total Assets 33 37 42 41 46 45 44 41 47 49

Profit Loss View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. TTM
Net Sales 30 36 40 41 43 49 49 48 59 66
Other Income 0 0 0 0 0 0 1 0 0 0
Total Income 31 36 40 41 43 49 50 49 59 66
Total Expenditure -28 -34 -37 -38 -41 -47 -47 -47 -57 -63
PBIDT 2 2 3 3 2 3 3 2 2 3
Interest -1 -1 -1 -2 -1 -1 -1 0 0 0
Depreciation 0 -1 -1 -1 -1 -1 -1 -1 -1 -1
Taxation 0 0 0 0 -1 0 0 0 -1 -1
Exceptional Items 0
PAT 1 1 0 1 0 1 1 1 1 2
Adjusted EPS 1 1 1 1 -1 1 1 1 1 2

Cash Flow View Details >>

Particulars 10 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. 0 5 -1 5 -1 5 1 4 6 8
Cash Fr. Inv. -1 -2 -1 0 0 -1 -1 0 0 -6
Cash Fr. Finan. 0 0 0 -2 -2 -2 -2 -4 -5 1
Net Change 0 3 -2 3 -3 2 -1 -1 0 3
Cash & Cash Eqvt 1 3 1 4 1 3 1 1 1 5

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 45.04 45.04 45.04 45.04 45.04 45.04 48.02 50.43 50.43
Public 54.96 54.96 54.96 54.96 54.96 54.96 51.98 49.57 49.57
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 12 Aug 2022
Intimation About Record Date
Intimation about Record Date
Fri, 12 Aug 2022
Intimation About The Annual General Meeting
Intimation about the Annual General Meeting
Fri, 12 Aug 2022
Intimation About Book Closure
Intimation about Book closure

Technical Scans View Details >>

Fri, 12 Aug 2022
High Delivery Percentage High Delivery Percentage
High Increase 1 Year High Increase 1 Year
High Increase 2 Years High Increase 2 Years
High Increase 5 Years High Increase 5 Years
Closing Near 50 SMA Closing Near 50 SMA

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 219,167.25 913.45 -0.8%
Divi's Laboratories Ltd. 98,918.90 3,726.20 -5.6%
Cipla Ltd. 82,906.37 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. 70,920.35 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. 62,010.73 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. 51,917.53 1,534.00 -0.1%
Piramal Enterprises Ltd. 45,855.65 1,921.35 +0.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 56.35 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 33.43 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-06 33.32 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 23.69 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 70.15 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 64.82 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-06 24.38 1,921.35 +0.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.37 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 8.44 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-06 3.86 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.50 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.43 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.12 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-06 1.28 1,921.35 +0.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-03 0.04 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 1.56 1,921.35 +0.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,921.35 +0.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,921.35 +0.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 13,993.30 1,921.35 +0.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 1,345.89 1,921.35 +0.8%

FAQ's On Sandu Pharmaceuticals Ltd.

Can I Buy Sandu Pharmaceutical Shares now?
What is the Share Price of Sandu Pharmaceutical?
What is the Relative Strength Index (RSI) Value of Sandu Pharmaceutical?
What is the Market Capital (MCAP) of Sandu Pharmaceutical?
What are the key metrics to analyse Sandu Pharmaceutical?
What is the Price Performance of Sandu Pharmaceutical?